Physician

Christopher Aaron Hess, M.D.

According to 2025 Medicare claims, Christopher Hess, M.D. (NPI: 1356631162) practices pain management in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is WILMINGTON HEALTH PLLC (NPI: 1881632339; TIN: 561980160) and primary practice location at 28412-2377. Hess is affiliated with the Physicians Healthcare Collaborative (ACO ID: D0068), participating under the REACH model.

Hess' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 439 traditional Medicare patients, billed 18,737 HCPCS/CPT codes, and received $278,218 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 558 prescription claims across 227 beneficiaries totaling $7,978 in drug costs, led by Baclofen (Baclofen). 2021 DME data shows 14 claims. Open Payments data shows 102 records totaling $2,057. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,506 to $278,218. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,080 and ending at $7,978. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	111	132	$16,506
2017	227	282	$31,330
2018	73	418	$41,563
2019	185	1,666	$67,322
2020	446	6,880	$240,975
2021	500	11,117	$349,628
2022	374	6,382	$202,225
2023	405	9,262	$255,635
2024	439	18,737	$278,218

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	35	75	$4,080
2016	91	274	$19,487
2017	76	244	$17,111
2018	75	579	$38,109
2019	105	317	$11,633
2020	200	650	$19,562
2021	318	1,069	$34,159
2022	167	465	$9,731
2023	147	364	$5,463
2024	227	558	$7,978

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	14	14	$11,175
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	158	212	$229
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	99	145	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	179	$91
J1010	Injection, methylprednisolone acetate, 1 mg	145	8,040	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	336	8,977	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Baclofen	Baclofen	212	9,757	$2,857
Gabapentin	Gabapentin	153	5,256	$1,232
Pregabalin	Pregabalin	39	1,164	$517
Methocarbamol	Methocarbamol	17	510	$180
Meloxicam	Meloxicam	39	1,431	$178

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	102	$2,057	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Aaron Hess, M.D.?

Tedicare shows public-source Medicare data for Christopher Aaron Hess, M.D. (NPI 1356631162), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Aaron Hess, M.D. have ACO affiliation data?

Christopher Aaron Hess, M.D. is shown with ACO affiliation data for Physicians Healthcare Collaborative (REACH, ACO ID D0068).

What billing organization is linked to Christopher Aaron Hess, M.D.?

Christopher Aaron Hess, M.D. is linked to WILMINGTON HEALTH PLLC (billing NPI 1881632339) in the available physician profile data.

Does Christopher Aaron Hess, M.D. have Open Payments data?

Christopher Aaron Hess, M.D. has 102 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.